Related Experiment Video
Updated: Aug 11, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient
Jean-Martin Boulanger1, Shelagh B Coutts, Michael Eliasziw
1Clinique Neuro Rive-Sud, 4896 Blvd Taschereau 250, Greenfield Park, Provinvr of Quebec, Canada, J4V 2J2. jbouboul@hotmail.com.
Background And Purpose:
Cerebral microhemorrhages (MHs) are common among patients presenting with acute ischemic stroke and may predict both subsequent ischemic and hemorrhagic strokes.
Methods:
We prospectively studied patients with and without MHs presenting within 12 hours of their ischemic stroke or transient ischemic attack (TIA). A magnetic resonance (MR) scan was performed within 24 hours of symptom(s) onset. The primary outcome was disabling or fatal stroke at 18 months.
Results:
An MR scan was done in 236 patients with acute ischemic stroke or TIA. Forty-five (19.1%) patients had an MH on a baseline MR scan. Patients with MHs were 2.8x (10.8% versus 4.0%; P=0.036) more likely to have a subsequent disabling or fatal stroke than patients without an MH. The risk of symptomatic intracerebral hemorrhage was not statistically significant among MH and non-MH patients (3.3% versus 0.8%; P=0.31).
Conclusions:
The presence of cerebral MH(s) in patients with acute ischemic stroke or TIA predicts recurrent disabling and fatal strokes. This risk is mainly assumed by recurrent ischemic strokes.
Insights
Cerebral microhemorrhages (MHs) in acute stroke patients predict disabling or fatal strokes. The increased risk is primarily due to recurrent ischemic events, not hemorrhagic ones.
Area of Science:
- Neurology
- Neuroimaging
- Stroke Medicine
Background:
- Cerebral microhemorrhages (MHs) are frequently observed in patients experiencing acute ischemic stroke.
- MHs may serve as indicators for future ischemic and hemorrhagic stroke events.
Purpose of the Study:
- To investigate the predictive value of MHs for subsequent disabling or fatal strokes.
- To assess the association between MHs and the risk of symptomatic intracerebral hemorrhage.
Main Methods:
- Prospective study of patients with and without MHs within 12 hours of ischemic stroke or TIA diagnosis.
- Magnetic resonance (MR) imaging performed within 24 hours of symptom onset.
- Primary outcome measured as disabling or fatal stroke at 18 months.
Main Results:
- MR scans were conducted on 236 patients; 19.1% showed MHs.
- Patients with MHs had a 2.8-fold increased likelihood of subsequent disabling or fatal stroke (10.8% vs. 4.0%, P=0.036).
- No statistically significant difference in symptomatic intracerebral hemorrhage risk was found between groups (3.3% vs. 0.8%, P=0.31).
Conclusions:
- The presence of cerebral MHs in acute stroke or TIA patients predicts recurrent disabling and fatal strokes.
- The elevated risk is predominantly driven by subsequent ischemic strokes.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Stroke: Introduction and Types
Ischemic Stroke l: Introduction

